What are the recommended vitamin A supplementation doses for infants (6–12 months), children ≥12 months, and pregnant or lactating women, and what precautions should be observed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vitamin A Supplementation Recommendations

For infants 6–12 months, provide 400 IU (approximately 150–300 µg/kg/day) of vitamin A daily; for children ≥12 months, ensure at least 600 IU/day through diet and/or supplementation; and for pregnant or lactating women, provide 600 IU/day during pregnancy and consider higher doses (up to 3000 µg retinol equivalents daily) only in populations with documented deficiency, avoiding high-dose supplementation during the first trimester due to teratogenic risk. 1, 2, 3

Infants (6–12 months)

  • Infants from 6 to 12 months require 400 IU (10 µg) daily to prevent deficiency, which is adequate for maintaining vitamin A stores and preventing rickets-related complications. 1

  • For parenteral administration in this age group, the dose is 150–300 µg/kg/day or approximately 2300 IU (697 µg) per day as a fixed dose. 4, 2

  • Premature infants have substantially higher needs: they require 700–1500 IU/kg/day (227–455 µg/kg/day) parenterally due to increased risk of deficiency and bronchopulmonary dysplasia. 4, 2

  • When administering parenteral vitamin A, always deliver it within a lipid emulsion rather than glucose-amino acid solutions, as photodegradation and adsorptive losses can exceed 60% in water-soluble preparations. 2

Children ≥12 Months

  • All children beyond 12 months of age need at least 600 IU/day (15 µg) of vitamin A through diet and/or supplementation to meet nutritional requirements. 1

  • For parenteral nutrition in children aged 1–18 years, provide 150 µg/day (approximately 500 IU). 4, 2

  • In populations where vitamin A deficiency is a documented public health problem, prophylactic supplementation should be given to all children aged 0–59 months. 5

  • High-dose supplementation (e.g., periodic large doses) is safe and cost-effective in deficiency-endemic areas, with kinetic modeling showing that even monthly inadvertent dosing is unlikely to cause toxic liver accumulation (>300 µg/g liver). 6

Pregnant Women

  • Pregnant women should receive 600 IU/day of vitamin A, preferably as part of a combined micronutrient preparation with iron and folic acid. 1

  • Most pregnant women in Western countries do not need supplementation if they consume the recommended dietary allowance during their reproductive years. 3

  • In developing countries where habitual intake is near basal needs, pregnant women should receive an additional 100 µg retinol equivalents (RE) during pregnancy. 3

  • Supplements should not exceed 3000 µg RE (10,000 IU) daily in women of childbearing age, as both hypo- and hypervitaminosis A can cause fetal harm. 7, 3

  • Assess vitamin A intake and serum levels before conception or early in pregnancy to guide supplementation and avoid teratogenic doses during the first trimester. 7, 8

Lactating Women

  • Lactating women in developing countries should receive an additional 300 µg RE daily to maintain adequate breast milk concentrations. 3

  • The first postpartum month is the only safe period for high-dose supplementation: a single dose of up to 400,000 IU within 6 weeks after delivery can benefit both mother and breastfeeding infant for several months. 5, 3

  • Routine supplementation beyond dietary intake is generally unnecessary in well-nourished populations, as increased consumption of vitamin A-rich foods can meet lactation needs. 3

Special Populations: Cystic Fibrosis with Pancreatic Insufficiency

  • Begin with low-dose preformed retinol and titrate rapidly to achieve serum retinol concentrations within the normal laboratory reference range. 7, 2

  • Alternatively, use β-carotene at 1 mg/kg/day (maximum 50 mg/day) for 12 weeks, followed by a maintenance dose not exceeding 10 mg/day. 7, 2

  • β-carotene is safer than preformed retinol because it is regulated by negative feedback and does not cause hypervitaminosis A. 7, 2

  • Monitor serum levels every 3–6 months after dose initiation or adjustment, then annually once stable normal levels are achieved. 7

Monitoring and Toxicity Precautions

  • **Serum retinol deficiency is defined as <0.70 µmol/L (approximately 200 µg/L)**, with normal range in children >6 months being 0.30–0.80 µmol/L. 2

  • Avoid monitoring during acute infections, as inflammatory responses transiently lower serum retinol and do not reflect true tissue stores. 7, 2

  • Water-soluble vitamin A formulations carry higher toxicity risk compared to oil-based preparations. 7, 2

  • Acute toxicity can occur with single doses >60,000 IU, while chronic toxicity may develop with daily intakes >25,000 IU sustained for more than six years. 2

  • Always factor in dietary vitamin A intake when prescribing supplements to avoid cumulative toxicity from combined sources. 7, 2

  • Toxicity is defined as hypercalcemia with serum 25-hydroxyvitamin D ≥250 nmol/L, accompanied by hypercalciuria and suppressed parathyroid hormone. 1

Key Clinical Pitfalls

  • Do not use high-dose vitamin A supplementation during the first trimester of pregnancy, as teratogenic effects can occur with excessive intake. 3, 8

  • Retinyl palmitate demonstrates greater stability than retinol in parenteral systems, making it the preferred formulation. 2

  • Vitamin A supplementation reduces all-cause mortality by 12% in children aged 6 months to 5 years in deficiency-endemic populations, making withholding supplementation unethical in documented deficiency settings. 9

  • Vomiting within 48 hours of supplementation occurs more frequently with vitamin A (RR 1.97), but this is generally transient and not a contraindication to continued use. 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.